1. Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation 
Jill C. Beck, John E. Wagner, Todd E. DeFor, Claudio G. Brunstein, Mark R. Schleiss, Jo-Anne Young, Daniel H. Weisdorf, Sarah Cooley, Jeffrey S. Miller, Michael R. Verneris 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 2, Pages (February 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of CMV reactivation by conditioning regimen. There is no significant difference between the myeloablative and nonmyeloablative conditioning.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Cumulative incidence of CMV reactivation by GVHD prophylaxis regimen. There is no significant difference between the ATG containing regimen (CsA/methylprednisone/ATG) and the non-ATG containing regimen (CsA/MMF).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions